Results 21 to 30 of about 375,109 (185)
Cefazolin-induced hemolytic anemia: a case report and systematic review of literature
European Journal of Medical Research, 2021 Background Cefazolin is a first-generation cephalosporin commonly used for skin and soft tissue infections, abdominal and orthopedic surgery prophylaxis, and methicillin-sensitive staph aureus.
Elizabeth Mause +2 more
doaj +1 more source
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Frontiers in Immunology, 2020 Autoimmune hemolytic anemias mediated by cold agglutinins can be divided into cold agglutinin disease (CAD), which is a well-defined clinicopathologic entity and a clonal lymphoproliferative disorder, and secondary cold agglutinin syndrome (CAS), in ...
S. Berentsen
semanticscholar +1 more source
Acute Tubular Necrosis Associated with Autoimmune Hemolytic Anemia due to Acute Gastroenteritis
Turkish Journal of Internal Medicine, 2021 Autoimmune hemolytic anemia (AIHA) is a rare disease with a rate of 1-3 in 100,000 in adults. AIHA are defined as primary (idiopathic) or secondary depending on the presence or absence of accompanying disease.
Mehmet Sezen +7 more
doaj +1 more source
The Changing Landscape of Autoimmune Hemolytic Anemia
Frontiers in Immunology, 2020 Autoimmune hemolytic anemia (AIHA) is a greatly heterogeneous disease due to autoantibodies directed against erythrocytes, with or without complement activation.
W. Barcellini, B. Fattizzo
semanticscholar +1 more source
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Journal of Clinical Medicine, 2020 Autoimmune hemolytic anemia (AIHA) is a highly heterogeneous disease due to increased destruction of autologous erythrocytes by autoantibodies with or without complement involvement. Other pathogenic mechanisms include hyper-activation of cellular immune
W. Barcellini +3 more
semanticscholar +1 more source
Autoimmune hemolytic anemia: current knowledge and perspectives
Immunity & Ageing, 2020 Autoimmune hemolytic anemia (AIHA) is an acquired, heterogeneous group of diseases which includes warm AIHA, cold agglutinin disease (CAD), mixed AIHA, paroxysmal cold hemoglobinuria and atypical AIHA.
S. Michalak +5 more
semanticscholar +1 more source
Case Reports in Oncology, 2019 Hemolytic anemia in the setting of malignancy is a rare manifestation of paraneoplastic syndrome with significant morbidity. Here we discuss a case involving metastatic breast cancer presenting with severe hemolytic anemia and renal failure secondary to ...
Eric H. Lee +3 more
doaj +1 more source
COVID-19 infection associated with autoimmune hemolytic anemia
Annals of Hematology, 2020 A 62-y-old man developed Covid-19 infection. Fourteen days after the first respiratory symptoms, he presented biological signs of hemolysis with cold agglutinins 1/16384.
A. Capes +4 more
semanticscholar +1 more source
COVID‐19 associated with severe autoimmune hemolytic anemia
Transfusion, 2020 Autoimmune hemolytic anemia (AIHA) has many known disease associations, including autoimmune, lymphoproliferative, and certain infectious diseases, as well as various medications. Studies have found that severe cases of coronavirus disease 2019 (COVID‐19)
J. Jacobs, Q. Eichbaum
semanticscholar +1 more source
A 22-month-old Boy with Acute Glomerulonephritis Coexistent with Hemolytic Anemia and Idiopathic Thrombocytopenia [PDF]
Childhood Kidney Diseases, 2015 Hemolytic anemia and thrombocytopenia are rare clinical manifestations of acute glomerulonephritis. Initially, in all such cases, a diagnosis of hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, systemic lupus erythematosus, and amyloidosis
Hye Won Park +3 more
doaj +1 more source